Wilshire Pharmaceuticals
NDC labeler code: 52536
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- ErythromycinEry, Ery-Tab · 5 products
- Erythromycin ethylsuccinateEry-Ped, E.E.S 400, E.E.S · 2 products
- Hydralazine hydrochloride and isosorbide dinitrateBidil · 1 product
- Testosterone cypionateDepo-Testosterone, Azmiro · 1 product
FDA applications for these products
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| April 24, 2019 | ANDA206368 | Testosterone cypionate TESTOSTERONE CYPIONATE | Wilshire Pharms Inc |
| June 23, 2005 | NDA020727 | Hydralazine hydrochloride and isosorbide dinitrate BIDIL | Azurity |
| March 29, 1982 | ANDA062298 | Erythromycin ERY-TAB | Pharmobedient |
| July 11, 1972 | ANDA061621 | Erythromycin ERYTHROMYCIN | Carnegie |
| April 2, 1965 | NDA050207 | Erythromycin ethylsuccinate E.E.S., ERYPED | Carnegie |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2023
-
February 15, 2023 · Class II · Terminated · D-0489-2023 · Testosterone cypionate
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
Testosterone Cypionate Injection, USP, CIII, 200 mg/mL, packaged in: a) 10 mL multiple-dose vials (NDC 52536-625-10) and b) 1 mL single dose vials (NDC 52536-625-01), Rx only, Mfd for: Wilshire Pharmaceuticals, Inc., Atl
2019
-
September 27, 2019 · Class III · Terminated · D-0167-2020 · Testosterone cypionate
Labeling:Label Mix-up: Shipper Carton labelled Testosterone Cypionate Injection, USP, 200mg/mL, 1 ml single-dose vials, found to contain shelf cartons labelled as Testosterone Cypionate Injection USP, 200mg/mL, 10 ml multi-dose vials which contain Testosterone Cypionate Injection USP, 200mg/mL,1mL single-does vials
Testosterone Cypionate Injection, USP, 2000 mg/10 mL, 1 mL Vial, Single-Dose, Rx only, Mfd. for: Wilshire Pharmaceuticals, Inc. Atlanta, GA 30328. NDC 52536-625-01
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026